Health

Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

- Data from first tranche of MSS CRC patients treated with ADG126 10 mg/kg every three weeks (Q3W) in dose expansionshowed clinical benefit including confirmed responses at higher, more frequent and repeat doses of the anti-CTLA-4 therapy - - Preliminary survival analysis of ADG126 10 mg/kg do...

2024-01-17 20:00 2873

Envision Energy Announces Collaboration with Five Global Healthcare Leaders to Unlock Renewable Energy in Davos

Envision Energy signed a three-year renewable energy supply agreement with AstraZeneca, Lonza, Novartis, Novo Nordisk and Roche, to offer around 200 gigawatt-hours (GWh) of green power annually from 2024, resulting in annual carbon dioxide equivalent savings of approximately 120,000 tons.  ...

2024-01-17 14:50 2453

SeptiCyte RAPID® By Immunexpress Receives Regulatory Clearance from Australian Therapeutic Goods Administration (TGA)

The Cost of Sepsis in Australia report (2021) estimated that there are >90,000 sepsis cases inAustralia each year and estimated direct and indirect costs of $700 million and $4 billion respectively SEATTLE and BRISBANE, Australia, Jan. 17, 2024 /PRNewswire/ -- Immunexpress, Pty Ltd., a molecular...

2024-01-17 06:00 1872

Epitomee® Announces Successful Completion of Pivotal Clinical Trial for Innovative Weight Loss Capsule

CAESAREA, Israel, Jan. 16, 2024 /PRNewswire/ -- Epitomee® announces the successful completion of the RESET pivotal clinical trial, for its weight loss capsule. The randomized placebo controlled, double blind trial, investigated the safety and efficacy of Epitomee® capsule versus the sham capsule ...

2024-01-16 21:00 1851

FIRST PATIENTS ENROLLED IN THE GORE VBX FORWARD CLINICAL STUDY

This study aims to compare the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease with the goal of informing practice guidelines around which modality is best suited for patients with this...

2024-01-16 21:00 1514

HOPE FOR FEMALE CANCER PATIENTS TO PRESERVE FERTILITY THROUGH OVARIAN TISSUE CRYOPRESERVATION AT SUNFERT

Sunfert International Fertility Centre is the First Private Oncofertility Hub in Malaysia KUALA LUMPUR, Malaysia, Jan. 16, 2024 /PRNewswire/ -- Reproductive medicine has achieved groundbreaking milestones, andMalaysia is one of the countries that is sought after by couples near and far to realis...

2024-01-16 18:14 1695

TVM Capital Healthcare invests in Vietnamese Eye Care Business Alina Vision in a Growth-Buy Out Transaction

Alina Vision operates hospitals in the underserved Vietnamese ophthalmology market, providing affordable and high-quality eye care services for people across all income levels to combat avoidable blindness; and meeting the impact investing strategy of TVM Capital Healthcare SINGAPORE and HANOI, ...

2024-01-16 16:55 2073

CELLSEARCH® CTC count proves its clinical utility in guiding therapeutic strategy supporting patient care in HR+/HER2- metastatic breast cancer

STIC CTC trial data published this November 2023 in the Journal of Clinical Oncology (JCO)demonstrate that CTC-guided treatment decision confers superior survival benefits in a subgroup of patients with hormone receptor (HR) positive)/human epidermal growth factor receptor (HER) 2 negative metast...

2024-01-16 15:00 1612

International Diabetes Federation and Sanofi Global Health Unit collaborate to strengthen diabetes response in 40 countries

The partnership will enhance diabetes care through training aimed at building capacity among healthcare professionals in low and middle-income countries. BRUSSELS, Jan. 16, 2024 /PRNewswire/ -- The International Diabetes Federation (IDF) , in collaboration with Sanofi's Global H...

2024-01-16 15:00 1449

Brain Navi Announces 100th Surgical Procedure Completed Using NaoTrac

HSINCHU, Jan. 16, 2024 /PRNewswire/ -- Brain Navi announced the completion of the 100th case utilizing its neurosurgical navigation robot NaoTrac. The 100th case has been performed by Neurosurgery Department Director Dr. Hao-Yu Chuang at Annan Hospital in Tainan,Taiwan.

2024-01-16 11:03 3422

FUST Lab's DEBREX, Surfactant-free Nano-Emulsion/Dispersion Equipment Enters the Japanese Market

SEOUL, South Korea, Jan. 16, 2024 /PRNewswire/ -- FUST Lab is a technology-based startup developing highly uniform nanoscale dispersion/emulsification technologies without surfactants, utilizing its original innovative ultrasonic technology. FUST Lab. is also a spin-off company from the Korea Re...

2024-01-16 09:00 1643

"CNB Amanah and 23 Century Introduce 'CELLTRUST,' Malaysia's Premier Comprehensive Health and Wealth Management Solution"

PETALING JAYA, Malaysia, Jan. 16, 2024 /PRNewswire/ -- CNB Amanah Berhad ("CNB Amanah") has partnered with 23 Century International Life Science Centre ("23 Century") to createMalaysia's premier stem cell management platform, 'CELLTRUST,' offering a comprehensive health and wealth management solu...

2024-01-16 08:00 2065

The Human Change campaign launched at World Economic Forum in Davos to make children's mental health a global priority

'Human change' is happening now, caused by the over-digitalization of children's lives –the world must prioritize the alignment of technological progress with the healthy development of children. DAVOS, Switzerland, Jan. 15, 2024 /PRNewswire/ -- Global advocacy campaign,  Human Change

2024-01-15 15:00 2116

NX China Takes Part in 9th Annual Medical Device Supply Chain Conference

TOKYO, Jan. 15, 2024 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereinafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., participated in the three-day 9th Annual Medical Device Supply Chain Conference held inChengdu, China, from November 25 to 27, 2023. Logo: https://kyo...

2024-01-15 14:00 1809

Amidst Ongoing Global Crises, Gates Foundation Announces Largest Annual Budget Ever: $8.6 Billion in 2024 to Save and Improve Lives

Increased funding includes support for health innovations that could save millions more lives by 2030 DAVOS, Switzerland, Jan. 15, 2024 /PRNewswire/ -- The Bill & Melinda Gates Foundation today announced its largest annual budget to date as it works toward the goal of a healthier, more prosperou...

2024-01-15 13:01 1429

SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India

SOPHiA GENETICS technology helps advance cancer research across India SOPHiA GENETICS and Karkinos Healthcare join forces to propel cutting-edge genomic solutions for breakthroughs in personalized cancer care inIndia BOSTON and ROLLE, Switzerland, Jan. 15, 2024 /PRNewswire/ -- SOPHiA GENETICS (N...

2024-01-15 12:00 1813

QBE Launches Direct-to-Consumer Home Insurance Package in Macau, and Pets are Included

* Home Plus Protection Package (HPPP) can be purchased online by homeowners, tenants or landlords using QBE's new online platform. * Uniquely, pet owners will be pleased to know their furry friends are likewise covered under HPPP. * Launch is part of QBE Asia's drive to deliver customer-cent...

2024-01-15 11:46 1821

Subject Enrollment Completed for International Multicenter Comparative Clinical (Phase 3) Study of Boan Biotech's Denosumab

A meeting was also held in Germany to announce the results of the international pharmacokinetic similarity clinical (Phase 1) study BERLIN, Jan. 12, 2024 /PRNewswire/ -- Boan Biotech recently announced that subject enrollment for the international multicenter comparative clinical (Phase 3) study...

2024-01-12 21:15 2856

RemeGen's RC88 Obtained FDA Fast Track Designation, Heralds New Hope for Ovarian Cancer Patients

YANTAI, China, Jan. 12, 2024 /PRNewswire/ -- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, announced recently that its independently developed mesothelin (MSLN)-targeting antibody-drug conjugate (ADC), RC88, has been granted Fast Tra...

2024-01-12 18:17 2025

U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS

The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements. DUBLIN, Calif. and JENA, Germany, Jan. 11, 2024 /PRNewswire/ -- Carl Zeiss Meditec AG -- ZEISS Medical Technology announced today that the U.S. ...

2024-01-11 20:00 1975
1 ... 85868788899091 ... 580

Week's Top Stories